Quinolinic acid up-regulates chemokine production and chemokine receptor expression in astrocytes

Advances in Experimental Medicine and Biology

Volumn 527, Issue , 2003, Pages 37-45

  Croitoru Lamoury, Juliana ^c   Guillemin, Gilles J ^a,b   Dormont, D ^c   Brew, Bruce J ^a  

^a ST VINCENT S HOSPITAL   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

^c INSTITUT DE RADIOPROTECTION ET DE SÛRETÉ NUCLÉAIRE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

CHEMOKINE; CHEMOKINE RECEPTOR; CYTOKINE; FRACTALKINE; GAMMA INTERFERON; INTERLEUKIN 8; MESSENGER RNA; MONOCYTE CHEMOTACTIC PROTEIN 1; QUINOLINIC ACID; RANTES; STROMAL CELL DERIVED FACTOR 1ALPHA; TUMOR NECROSIS FACTOR ALPHA;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ASTROCYTE; CELL CULTURE; CONFERENCE PAPER; CONTROLLED STUDY; CYTOKINE PRODUCTION; ENCEPHALITIS; ENZYME LINKED IMMUNOSORBENT ASSAY; FETUS; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; UPREGULATION;

EID: 1042291138     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4615-0135-0_4     Document Type: Conference Paper

References (63)

1. T.W. Stone, Endogenous neurotoxins from tryptophan, Toxicon 39, 61-73 (2001).
2. P. Conti, R.C. Barbacane, M. Reale, Chemokines in inflammatory states, Allergy Asthma Proc. 20, 205-208 (1999).
3. R.S. Ghimikar, Y.L. Lee, L.F. Eng, Inflammation in traumatic brain injury: role of cytokines and chemokines, Neurochem. Res. 23, 329-340 (1998).
4. B.A. Premack, T.J. Schall, Chemokine receptors: gateways to inflammation and infection, Nature Medecine 2, 1174-1178 (1996).
5. M. Baggiolini, Chemokines and leukocyte traffic, Nature 392, 565-568 (1998).
6. F. Balkwill, The molecular and cellular biology of the chemokines, J. Viral Hepat. 5, 1-14 (1998).
7. P.M. Murphy, M. Baggiolini, I.F. Charo, C.A. Hebert, R. Horuk, K. Matsushima, L.H, Miller, J.J. Oppenheim, C.A. Power, International union of pharmacology. XXII. Nomenclature for chemokine receptors, Pharmacol. Rev. 52, 145-176 (2000).
8. J.M. Weiss, S.A. Downie, W.D. Lyman, J.W. Berman, Astrocyte-derived monocyte-chemoattractant protein-1 directs the transmigration of leukocytes across a model of the human blood-brain barrier, J. Immunol. 161, 6896-6903 (1998).
9. P. Bezzi, M. Domercq, L. Brambilla, R. Galli, D. Schols, E. De Clercq, A. Vescovi, G. Bagetta, G. Kollias, J. Meldolesi, A. Volterra, CXCR4-activated astrocyte glutamate release via TNFalpha: amplification by microglia triggers neurotoxicity, Nat. Neurosci. 4, 702-710 (2001).
10. M. Cota, A. Kleinschmidt, F. Ceccherini-Silberstein, F. Aloisi, M. Mengozzi, A. Mantovani, R. Brack-Wemer, G. Poli, Upregulated expression of interleukin-8, RANTES and chemokine receptors in human astrocytic cells infected with HIV-1, J. Neurovirol. 6, 75-83 (2000).
11. J. Croitoru-Lamoury, G. Guillemin, F.D. Boussin, B. Mognetti, S. Lebel-Binay, T. Leveque, G. Gras, R. Le Grand, D. Dormont, Expression of chemokines and their receptors in human and simian astrocytes: evidence for a central role of TNF-a and IFN-g in CXCR4 and CCR5 modulation, Glia in press. (2002).
12. J.W. Oh, L.M. Schwiebert, E.N. Benveniste, Cytokine regulation of CC and CXC chemokine expression by human astrocytes, J. Neurovirol. 5, 82-94 (1999).
13. P. Rezaie, G. Trillo-Pazos, I.P. Everall, D.K. Male, Expression of beta-chemokines and chemokine receptors in human fetal astrocyte and microglial co-cultures: potential role of chemokines in the developing CNS, Glia 37, 64-75 (2002).
14. V.C. Asensio, I.L. Campbell, Chemokines in the CNS: plurifunctional mediators in diverse states, Trends Neurosci. 22, 504-512 (1999).
15. A.R. Glabinski, R.M. Ransohoff, Chemokines and chemokine receptors in CNS pathology. J. Neurovirol. 5, 3-12 (1999).
16. A.E.I. Proudfoot, Chemokine receptors: multifaceted therapeutic targets, Nat. Rev. Immunol. 2, 106-115 (2002).
17. B. Moser, Chemokines and HIV: a remarkable synergism, Trends in Microbiology 5, 88-90 (1997).
18. A. Boutet, H. Salim, Y. Taoufik, P.M. Lledo, J.D. Vincent, J.F. Delfraissy, M. Tardieu, Isolated human astrocytes are not susceptible to infection by M- and T-tropic HIV-1 strains despite functional expression of the chemokine receptors CCR5 and CXCR4, Glia 34, 165-177 (2001).
19. D. Gabuzda, J. Wang, Chemokine receptors and virus entry in the central nervous system. J. Neurovirol. 5, 643-658 (1999).
20. J. Hesselgesser, R. Horuk, Chemokine and chemokine receptor expression in the central nervous system, J. Neurovirol. 5, 13-26 (1999).
21. A.V. Andjelkovic, D. Kerkovich, J. Shanley, L. Pulliam, J.S. Pachter, Expression of binding sites for beta chemokines on human astrocytes, Glia 28, 225-235 (1999).
22. M.E. Dorf, M.A. Berman, S. Tanabe, M. Heesen, Y. Luo, Astrocytes express functional chemokine receptors, J. Neuroimmunol. 111, 109-121 (2000).
23. R.S. Klein, K.C. Williams, X. Alvarez-Hemandez, S. Westmoreland, T. Force, A.A. Lackner, A.D. Luster, Chemokine receptor expression and signaling in macaque and human fetal neurons and astrocytes: implications for the neuropathogenesis of AIDS, J. Immunol. 163, 1636-1646 (1999).
24. F. Sabri, E. Tresoldi, M. Di Stefano, S. Polo, M.C. Monaco, A. Verani, J.R. Fiore, P. Lusso, E. Major, F. Chiodi, G. Scarlatti, Nonproductive human immunodeficiency virus type 1 infection of human fetal astrocytes: independence from CD4 and major chemokine receptors, Virology 264, 370-384 (1999).
25. R.R. Brown, Y. Ozaki, S.P. Datta, E.C. Borden, P.M. Sondel, D.G. Malone, Implications of interferon-induced tryptophan catabolism in cancer, auto-immune diseases and AIDS, Adv. Exp. Med. Biol. 294, 425-435 (1991).
26. J.M. Carlin, Y. Ozaki, G.I. Byrne, R.R. Brown, E.C. Borden, Interferons and indoleamine 2,3-dioxygenase: role in antimicrobial and antitumor effects, Experientia 45, 535-541 (1989).
27. G. Melillo, G.W. Cox, A. Biragyn, L.A. Sheffler, L. Varesio, Regulation of nitric-oxide synthase mRNA expression by interferon-gamma and picolinic acid, J. Biol. Chem. 269, 8128-8133 (1994).
28. Y. Ozaki, M.P. Edelstein, D.S. Duch, Induction of indoleamine 2,3-dioxygenase: a mechanism of the antitumor activity of interferon gamma, Proc. Natl. Acad. Sci. U. S. A. 85, 1242-1246 (1988).
29. Y. Kudo, C.A. Boyd, Human placental indoleamine 2,3-dioxygenase: cellular localization and characterization of an enzyme preventing fetal rejection, Biochim. Biophys. Acta 1500, 119-124 (2000).
30. T. Nicholls, B. Lacey, I. Nitsos, G. Smythe, D.W. Walker, Regional changes in kynurenic acid, quinolinic acid, and glial fibrillary acidic protein concentrations in the fetal sheep brain after experimentally induced placental insufficiency, Am. J. Obstet. Gynecol. 184, 203-208 (2001).
31. G. Melillo, G.W. Cox, D. Radzioch, L. Varesio, Picolinic acid, a catabolite of L-tryptophan, is a costimulus for the induction of reactive nitrogen intermediate production in murine macrophages, J. Immunol. 150, 4031-4040 (1993).
32. M.C. Bosco, A. Rapisarda, S. Massazza, G. Melillo, H. Young, L. Varesio, The tryptophan catabolite picolinic acid selectively induces the chemokines macrophage inflammatory protein-1 alpha and -1beta in macrophages [In Process Citation]. J. Immunol. 164, 3283-3291 (2000).
33. B.J. Brew, L. Pemberton, L. Evans, M. Heyes, Quinolinic acid production by macrophages infected with demented and non-demented isolates of HIV, Clin. Neuropathol. 12, S1 (1993).
34. M.P. Heyes, B.J. Brew, A. Martin, R.W. Price, A.M. Salazar, J.J. Sidtis, J.A. Yergey, M.M. Mouradian, A.E. Salder, J. Keilp, D. Rubinow, S.P. Markey, Quinolinic acid in cerebrospinal fluid and serum in HIV-1 infection: relationship to clinical and neurological status, Ann. Neurol. 29, 202-209 (1991).
35. B.J. Brew, L. Pemberton, P. Cunningham, M.G. Law, Levels of human immunodeficiency virus type 1 RNA in cerebrospinal fluid correlate with AIDS dementia stage, J. Infect. Dis. 175, 963-966 (1997).
36. M.G. Espey, O.N. Chernyshev, J.J. Reinhard, M.A. Namboodiri, C.A. Colton, Activated human microglia produce the excitotoxin quinolinic acid, Neuroreport 8, 431-434 (1997).
37. G.J. Guillemin, S.J. Kerr, G.A. Smythe, D.G. Smith, V. Kapoor, P.J. Armati, J. Croitoru, B.J. Brew, Kynurenine pathway metabolism in human astrocytes: a paradox for neuronal protection, J. Neurochem. 78, 1-13 (2001).
38. J. Croitoru, G. Guillemin, F.D. Boussin, B. Mognetti, S. Lebel-Binay, T. Leveque, G. Gras, R. Le Grand, D. Dormont, Chemokines and chemokine receptors expression in simian astrocytes, SSA. Trav. Scient. 20, 141-142 (1999).
39. A.V. Andjelkovic, D. Kerkovich, J.S. Pachter, Monocyte:astrocyte interactions regulate MCP-1 expression in both cell types, J. Leukoc. Biol. 68, 545-552 (2000).
40. D.A. Barnes, M. Huston, R. Holmes, E.N. Benveniste, V.W. Yong, P. Scholz, H.D. Perez, Induction of RANTES expression by astrocytes and astrocytoma cell lines, J. Neuroimmunol. 71, 207-214 (1996).
41. H. Guo, Y.X. Jin, M. Ishikawa, Y.M. Huang, P.H. van der Meide, H. Link, B.G. Xiao, Regulation of beta-chemokine mRNA expression in adult rat astrocytes by lipopolysaccharide, proinflammatory and immunoregulatory cytokines, Scand. J. Immunol. 48, 502-508 (1998).
42. N. Janabi, I. Hau, M. Tardieu, Negative Feedback Between Prostaglandin and alpha- and beta-Chemokine Synthesis in Human Microglial Cells and Astrocytes, J. Immunol. 162, 1701-1706 (1999).
43. P.K. Peterson, S. Hu, J. Salak-Johnson, T.W. Molitor, C.C. Chao, Differential production of and migratory response to beta chemokines by human microglia and astrocytes, J. Infect. Dis. 175, 478-481 (1997).
44. D. Sun, X. Hu, X. Liu, J.N. Whitaker, W.S. Walker, Expression of chemokine genes in rat glial cells: the effect of myelin basic protein-reactive encephalitogenic T cells, J. Neurosci. Res. 48, 192-200 (1997).
45. A.V. Andjelkovic, D.D. Spencer, J.S. Pachter, Visualization of chemokine binding sites on human brain microvessels, J. Cell. Biol. 145, 403-412 (1999).
46. R. Brack-Werner, Astrocytes: HIV cellular reservoirs and important participants in neuropathogenesis, Aids 13, 1-22 (1999).
47. C.C. Bleul, M. Farzan, H. Choe, C. Parolin, J. Clark-Lewis, J. Sodroski, T.A. Springer, The lymphocyte chemoattractant SDF-1 is a ligand for LESTER/ fusin and blocks HIV-1 entry, Nature 382, 829-832 (1996).
48. J.M. Farber, Mig and IP-10: CXC chemokines that target lymphocytes, J. Leukoc. Biol. 61, 246-257 (1997).
49. D. Maciejewski-Lenoir, S. Chen, L. Feng, R. Maki, K.B. Bacon, Characterization of fractalkine in rat brain cells: migratory and activation signals for CX3CR-1-expressing microglia, J. Immunol. 163, 1628-1635 (1999).
50. O. Meucci, A. Fatatis, A.A. Simen, R.J. Miller, Expression of CX3CR1 chemokine receptors on neurons and their role in neuronal survival, Proc. Natl. Acad. Sci. U. S. A. 97, 8075-8080 (2000).
51. S.A. Boehme, F.M. Lio, D. Maciejewski-Lenoir, K.B. Bacon, P.J. Conlon, The chemokine fractalkine inhibits Fas-mediated cell death of brain microglia, J. Immunol. 165, 397-403 (2000).
52. A.V. Vallat, U. De Girolami, J. He, A. Mhashilkar, W. Marasco, B. Shi, F. Gray, J. Bell, C. Keohane, T.W. Smith, D. Gabuzda, Localization of HlV-1 co-receptors CCR5 and CXCR4 in the brain of children with AIDS Am. J. Pathol. 152, 167-178 (1998).
53. M.Q. Xia, S.X. Qin, L.J. Wu, C.R. Mackay, B.T. Hyman, Immunohistochemical study of the beta-chemokine receptors CCR3 and CCR5 and their ligands in normal and Alzheimer's disease brains. Am. J. Pathol. 153, 31-37 (1998).
54. L. Zhang, T. He, A. Talal, G. Wang, S.S. Frankel, D.D. Ho, In vivo distribution of the human immunodeficiency virus/simian immunodeficiency virus coreceptors: CXCR4, CCR3, and CCR5, J. Virol. 72, 5035-5045 (1998).
55. M.P. Heyes, K.J. Swartz, S.P. Markey, M.F. Beal, Regional brain and cerebrospinal fluid quinolinic acid concentrations in Huntington's disease, Neurosci. Lett. 122, 265-269 (1991).
56. Y.R. Zou, A.H. Kottmann, M. Kuroda, I. Taniuchi, D.R. Littman, Function of the chemokine receptor CXCR4 in haematopoiesis and in cerebellar development, Nature 393, 595-599 (1998).
57. J.B. Rottman, K.P. Ganley, K. Williams, L. Wu, C.R. Mackay, D.J. Ringler, Cellular localization of the chemokine receptor CCR5. Correlation to cellular targets of HIV-1 infection, Am. J. Pathol. 151, 1341-1351 (1997).
58. S.J. Kerr, P.J. Armati, L.A. Pemberton, G. Smythe, B. Tattam, B.J. Brew, Kynurenine pathway inhibition reduces toxicity of HIV-infected macrophages, Neurology 49, 1671-1681 (1997).
59. S.J, Kerr, P.J. Armati, G.J. Guillemin, B.J. Brew, Chronic exposure of human neurons to quinolinic acid results in neuronal changes consistent with AIDS dementia complex, AIDS 12, 355-363 (1998).
60. L.A. Pemberton, S.J. Kerr, B.J. Brew, HlV-1 gp120 does not induce quinolinic acid production by macrophages (Letter), J. NeuroVirol. 3, 86-87 (1997).
61. D.G. Smith, G.J. Guillemin, L. Pemberton, S. Kerr, A. Nath, G.A. Smythe, B.J. Brew, Quinolinic acid is produced by macrophages stimulated by platelet activating factor, Nef and Tat, J. Neurovirol. 7, 56-60 (2001).
62. J.T. Coyle, R. Schwarcz, Mind glue: implications of glial cell biology for psychiatry, Arch. Gen. Psychiatry. 57, 90-93 (2000).
63. K.B. Bacon, J.K. Harrison, Chemokines and their receptors in neurobiology: perspectives in physiology and homeostasis. J. Neuroimmunol. 104, 92-97 (2000).